Drug Enforcement Administration sends second attempt at a telehealth prescribing rule to executive budget office
The Drug Enforcement Administration’s long-awaited second attempt at a telemedicine prescribing rule has been handed off to the Office of Management and Budget (OMB) for review. The rule is a major issue for telehealth companies that allow for the prescription of controlled substances, such as Adderall for ADHD, testosterone for transgender men, and buprenorphine for opioid use disorder.
Other Articles in this Edition
Struggling telehealth company exploited Adderall sales for profit, prosecutors say
A.D.H.D. Startup Executives Accused of $100 Million Fraud in Adderall Scheme
The ADHD Drug Shortage Could Get Even Worse Thanks to One Telehealth Company
TikTok and ADHD Misinformation
First-Ever Therapeutic Video Game for Adult ADHD Approved By FDA
Symptom Improvement Found Across Diagnoses With Placebo
Sleep disorders in childhood found to increase the risk of developing ADHD symptoms
Teenagers with ADHD more likely to self-harm, research shows
Childhood Physical Health and ADHD Symptoms
Mealtimes can be tough when your child is autistic or has ADHD. Here are 5 tips to try